This work presents a fully integrated, high precision and low power readout front end for in vivo Electrochemical Impedance Spectroscopy applications. The operation is based on the digital synchronous detection of the magnitude and phase shift. This is enabled using a compact and fully integrated sinusoidal signal generator to produce the interrogation frequencies that are injected into the testing sample. The readout system includes an asynchronous measurement mode at high frequencies to reduce the error. It also offers a simple structure with low component count making it suitable for biomedical implants and integration in array structures. The system is designed and simulated on a 45nm CMOS process and consumes $60\mu A$ at a 1V supply. It can measure the impedance over a frequency range from 1mHz to 100kHz.
Application-Specific Integrated Circuits (ASICs) are fundamental to the development of advanced medical devices and diagnostic tools for biomedical applications and smart healthcare. They offer significant advantages in performance, power efficiency, and miniaturization, which are essential for meeting the stringent requirements of modern medical technologies. However, the adoption of ASICs is often hindered by challenges such as long design cycles, high development costs, and limited application scope. Traditionally, the design of ASICs for biomedical applications has been driven by the assumption that each application requires a unique, customized solution. While this may be true from a clinical perspective, a technological analysis reveals common requirements across different biomedical applications, such as signal acquisition, amplification, filtering, and data processing. This work proposes a shift toward a multimodal design strategy using Universal Multimodal Actuator Sensor Chips (UMASCs). It presents an analysis of the design considerations for implementing UMASCs in biomedical contexts, exploring their potential to standardize hardware across clinically diverse techniques.
This work presents a compact, low-power temperature sensor with a native spiking output, suitable for integration in neuromorphic and event-driven systems. Unlike conventional approaches that rely on analog front ends, comparators, or ADCs to digitize temperature, the proposed circuit merges sensing and encoding by directly proposing tunable proportional-to-absolute-temperature (PTAT) sensing. The tunable PTAT voltage is applied to a single adjustable Schmitt trigger, which generates spikes only when the temperature deviates by a programmable threshold $\Delta T$, enabling event-driven operation with minimal static energy overhead. Implemented in a 45 nm CMOS process with a 1 V supply, the design consumes 650 nW of power. Simulated results demonstrate correct spiking across 0° C to 80° C with $\Delta \mathrm{T}$ steps of a few degrees Celsius, while maintaining robustness under process and mismatch variations. The entire system occupies a small footprint of $\text{1 0 0} \mu \mathrm{m}^{\mathrm{2}}$.
11 December 2025 in IEEE Transactions on Biomedical Circuits and Systems
We present in this paper an implantable closed-loop neuromodulation prototype system for type 2 diabetes (T2D) management, which leverages pancreatic electrophysiology as both a sensing and therapeutic modality. Among candidate biomarkers, the fraction of plateau phase (FOPP) emerges as a robust indicator of glucose dynamics. Hence, the neural interface is optimized for low-power measurement of the electrical activity of the beta-cells with high accuracy in direct readout mode and long-term monitoring in FOPP mode. The experimental framework was established using a perfused pancreas model, first in mice and then optimized for rats, with glucose-dependent signals captured via a custom 16-channel neural interface. Results confirmed the feasibility of extracting FOPP in ex vivo settings, though signal complexity differed from isolated islets in vitro. Additionally, a fabricated 8-channel electrical stimulator with adjustable current levels and optimized charge balancing technique, demonstrated the capability to meet physiological requirements for beta-cell activation. While integration of AI-based classifiers for advanced FOPP–glucose correlation remains a future step, this study establishes the foundational experimental and technological evidence for a next-generation closed-loop neuromodulator.
1 January 2025 in IEEE Solid-State Circuits Magazine